Impact of immunosuppressive and antifungal drugs on PBMC- and whole blood-based flow cytometric CD154+ Aspergillus fumigatus specific T-cell quantification-Reference-Cited by-同舟云学术

Impact of immunosuppressive and antifungal drugs on PBMC- and whole blood-based flow cytometric CD154+ Aspergillus fumigatus specific T-cell quantification

Published:2020-03-31 Issue:5 Volume:209 Page:579-592
ISSN:0300-8584
Container-title:Medical Microbiology and Immunology
language:en
Short-container-title:Med Microbiol Immunol

Author:

Page Lukas,Lauruschkat Chris D.,Helm Johanna,Weis Philipp,Lazariotou Maria,Einsele Hermann,Ullmann Andrew J.,Loeffler Juergen,Wurster Sebastian^ORCID

Funder

Deutsche Forschungsgemeinschaft

IZKF Wuerzburg

Bayerisches Staatsministerium für Wirtschaft und Medien, Energie und Technologie

Publisher

Springer Science and Business Media LLC

Subject

Microbiology (medical),Immunology,General Medicine,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s00430-020-00665-3.pdf

Reference56 articles.

1. Park SJ, Mehrad B (2009) Innate immunity to Aspergillus species. Clin Microbiol Rev 22:535–551

2. Fukuda T, Boeckh M, Carter RA, Sandmaier BM, Maris MB, Maloney DG, Martin PJ, Storb RF, Marr KA (2003) Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning. Blood 102:827–833

3. Chamilos G, Lewis RE, Kontoyiannis DP (2008) Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis. Clin Infect Dis 47:503–509

4. Cornely OA, Arikan-Akdagli S, Dannaoui E, Groll AH, Lagrou K, Chakrabarti A, Lanternier F, Pagano L, Skiada A, Akova M, Arendrup MC, Boekhout T, Chowdhary A, Cuenca-Estrella M, Freiberger T, Guinea J, Guarro J, de Hoog S, Hope W, Johnson E, Kathuria S, Lackner M, Lass-Florl C, Lortholary O, Meis JF, Meletiadis J, Munoz P, Richardson M, Roilides E, Tortorano AM, Ullmann AJ, van Diepeningen A, Verweij P, Petrikkos G, European Society of Clinical M, Infectious Diseases Fungal Infection Study G (2014) ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis. Clin Microbiol Infect 20(Suppl 3):5–26

5. Johnson G, Ferrini A, Dolan SK, Nolan T, Agrawal S, Doyle S, Bustin SA (2014) Biomarkers for invasive aspergillosis: the challenges continue. Biomark Med 8:429–451

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification and validation of diagnostic cut-offs of the ELISpot assay for the diagnosis of invasive aspergillosis in high-risk patients;PLOS ONE;2024-07-09

2. Blockade of the PD-1/PD-L1 Immune Checkpoint Pathway Improves Infection Outcomes and Enhances Fungicidal Host Defense in a Murine Model of Invasive Pulmonary Mucormycosis;Frontiers in Immunology;2022-02-18

3. Development of a Simple and Robust Whole Blood Assay with Dual Co-Stimulation to Quantify the Release of T-Cellular Signature Cytokines in Response to Aspergillus fumigatus Antigens;Journal of Fungi;2021-06-08